Oncology
Jeremy Abramson, MD
Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Jeremy S. Abramson, MD, MMSc, is the Director of the Lymphoma Program and holds the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center. As an Associate Professor of Medicine at Harvard Medical School, he specializes in lymphoid malignancies, treating all subtypes of non-Hodgkin lymphoma (including B-cell and T-cell lymphomas), Hodgkin lymphoma, and chronic lymphocytic leukemia (CLL). Dr. Abramson leads a multidisciplinary team comprising medical oncologis
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
- Hematology (American Board of Internal Medicine)
Education & Training
- Mount Sinai School of Medicine (Icahn School of Medicine at Mount Sinai) — M.D., 2000
- Harvard Medical School — MMSc
- Massachusetts General Hospital — Residency, Internal Medicine, 2001-2003
- Dana-Farber Cancer Institute — Fellowship, Hematology and Oncology, 2003-2006
Peer Recognition
2017, 2019-2025 (8 years)
- Castle Connolly — Top Doctor
2017-2026 (10 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Massachusetts General Hospital
- Mass General Brigham Cancer Institute
- Massachusetts General Hospital, Boston, MA
Languages
English
Experience
25+ years in practice